Idaho, Kansas and Missouri can proceed with their push against abortion pill mifepristone, a judge in Texas ruled Thursday. The big picture: The Republican-led states are seeking to roll back federal rules on the drug to make it harder for people to access the abortion pill through telehealth prescriptions.

The FDA announced on Wednesday that it has banned the use of Red No. 3, an additive used to give food and drinks a cherry-red color.

Trump-appointed Judge Matthew Kacsmaryk ruled Thursday that Idaho, Kansas, and Missouri can pursue legal action to prohibit the FDA from allowing online prescriptions.

Shoppers warned do not eat bacteria infested cheddar cheese from Lidl - Listeria can cause flu like symptoms and even meningitis in severe cases

The Republican-led states of Idaho, Missouri and Kansas can proceed with a lawsuit seeking to restrict the availability of the abortion pill mifepristone in the United States, a federal judge in Texas ruled on Thursday.

Statesman columnist Bridget Grumet speaks about her trip to Delaware to investigate the access Texas women have to abortion by mail.

Walmart has recalled more than 2,000 cases of Great Value Family Size Chicken Broth sold in Texas and eight other states.

Texas has outlawed most abortions and forbids sending abortion medication through the mail. Still, thousands obtain abortion pills online – some coming from Delaware.

The states of Idaho, Kansas and Missouri made the request in U.S. District Court in Amarillo, Texas. The only judge based there is Matthew Kacsmaryk, a nominee of former President Donald Trump who previously ruled in favor of a challenge to the pill’s approval.

In our news wrap Wednesday, the FDA says it is banning red dye No. 3 from food for its potential cancer risk, the Supreme Court signaled support for a Texas law aimed at blocking children from seeing pornography online,

And only a fraction of patients have their hypertension well-controlled, meaning there’s a need for novel strategies. The Food and Drug Administration approved that “renal denervation” option about a year ago, based on studies showing a modest benefit in patients whose blood pressure remains high despite multiple medicines.